Combination with betalactamase inhibitor results in an antibiotic with increased spectrum of action with coverage against Staphylococcus aureus, E.coli, Proteus, Klebsiella, Salmonella, Shigella, H. influenzae, N. Gonorrhoea & Bacteroids fragilis
Well tolerated by patients with high safety profile